Literature DB >> 817771

Evidence for familial immune defect in meningococcal meningitis.

H C Whittle, A Oduloju, G Evans-Jones, B M Greenwood.   

Abstract

Twenty-six patients who had recovered from group A meningococcal meningitis were vaccinated with group C meningococcal polysaccharide and tetanus toxoid. Their haemagglutinating antibody response was measured two weeks later and compared with those of 22 siblings and 39 controls. Patients and siblings had a significantly lower antibody response to the group C vaccine but not to tetanus toxoid. This suggests that patients susceptible to meningococcal disease may have an immune defect involving their response to meningococcal polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 817771      PMCID: PMC1639823          DOI: 10.1136/bmj.1.6020.1247

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Spread of meningococcal infection within households.

Authors:  R S Munford; A de E Taunay; J S de Morais; D W Fraser; R A Feldman
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

2.  Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.

Authors:  T A Hoffman; E A Edwards
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  Human cell-surface structures related to Haemophilus influenzae type B disease.

Authors:  J K Whisnant; G N Rogentine; D L Mann; J B Robbins
Journal:  Lancet       Date:  1971-10-23       Impact factor: 79.321

4.  Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections.

Authors:  B M Greenwood; H C Whittle; O Dominic-Rajkovic
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

5.  Serum immunoglobulin concentrations in epidemic meningococcal meningitis in Niger.

Authors:  D S Rowe; M Vandekerkove; B Grab
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

6.  Antigen-negative meningitis due to group A Neisseria meningitidis.

Authors:  B M Greenwood; H C Whittle
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

7.  Serologic studies of meningococcal infection and polysaccharide vaccination.

Authors:  M S Artenstein; B L Brandt; E C Tramont; W C Branche; H D Fleet; R L Cohen
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

8.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  6 in total

1.  Meningococcal septicaemia.

Authors:  K Webb
Journal:  Proc R Soc Med       Date:  1976-12

2.  Carriage of Neisseria meningitidis: investigations in a military establishment.

Authors:  J V Pether; N F Lightfoot; R J Scott; J Morgan; A P Steele-Perkins; S C Sheard
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

3.  Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.

Authors:  Rachel A Foster; Jennifer Carlring; Michael W McKendrick; Andrew Lees; Ray Borrow; Robert C Read; Andrew W Heath
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

4.  Immunological competence of children with pyogenic meningitis.

Authors:  L J Beard; Y H Thong
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

5.  Meningococcal infections in the Hamilton area during 1978.

Authors:  S Fawcett; M R Achong; C Adeniyi-Jones
Journal:  Can Med Assoc J       Date:  1980-03-08       Impact factor: 8.262

6.  Prognostic factors in acute meningococcaemia.

Authors:  L S Lewis
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.